Current position:Home >Product >
		
		
	
3H-1,2,4-Triazol-3-one, 1,2-dihydro-5-methoxy-1-(2-methoxy-1-methylethyl)-
3H-1,2,4-Triazol-3-one, 1,2-dihydro-5-methoxy-1-(2-methoxy-1-methylethyl)-(66501-17-5)
- Name: 3H-1,2,4-Triazol-3-one, 1,2-dihydro-5-methoxy-1-(2-methoxy-1-methylethyl)-
- Synonyms:
- Molecular Formula:C7H13N3O3
- Molecular Weight:
- CAS Registry Number:66501-17-5
- EINECS:
- Melting Point:
- Water Solubility:
 
	   Other Product
- 665011-50-7/Acetamide, N-[[(5S)-3-[3-fluoro-4-[4-(pyrazinylcarbonyl)-1-piperazinyl]phenyl]-2-oxo- 5-oxazolidinyl]methyl]-
- 665011-52-9/Acetamide, N-[[(5S)-3-[3-fluoro-4-[4-[(5-methyl-3-isoxazolyl)carbonyl]-1-piperazinyl] phenyl]-2-oxo-5-oxazolidinyl]methyl]-
- 66501-15-3/2-Quinoxalinecarboxamide, N-(hydroxymethyl)-3,7-dimethyl-, 1,4-dioxide
- 665011-54-1/Acetamide, N-[[(5S)-3-[3-fluoro-4-[4-(1H-imidazol-2-ylcarbonyl)-1-piperazinyl]phenyl ]-2-oxo-5-oxazolidinyl]methyl]-
- 665011-59-6/Acetamide, N-[[(5S)-3-[4-[4-(cyclobutylcarbonyl)-1-piperazinyl]-3-fluorophenyl]-2-oxo -5-oxazolidinyl]methyl]-
- 665011-61-0/1-Pyrrolidinecarboxylic acid, 2-[[4-[4-[(5S)-5-[(acetylamino)methyl]-2-oxo-3-oxazolidinyl]-2-fluorophen yl]-1-piperazinyl]carbonyl]-, 1,1-dimethylethyl ester, (2S)-
- 665011-62-1/Carbamic acid, [2-[4-[4-[(5S)-5-[(acetylamino)methyl]-2-oxo-3-oxazolidinyl]-2-fluorophen yl]-1-piperazinyl]-2-oxoethyl]-, 1,1-dimethylethyl ester
- 665011-67-6/Acetamide, N-[[(5S)-3-[3-fluoro-4-[4-(pyrazinylthioxomethyl)-1-piperazinyl]phenyl]-2- oxo-5-oxazolidinyl]methyl]-
- 665011-68-7/Acetamide, N-[[(5S)-3-[3-fluoro-4-[4-[(5-methylpyrazinyl)thioxomethyl]-1-piperazinyl] phenyl]-2-oxo-5-oxazolidinyl]methyl]-
- 665011-69-8/Carbamic acid, [2-[4-[4-[(5S)-5-[(acetylamino)methyl]-2-oxo-3-oxazolidinyl]-2-fluorophen yl]-1-piperazinyl]-2-thioxoethyl]-, 1,1-dimethylethyl ester
- 66501-17-5/3H-1,2,4-Triazol-3-one, 1,2-dihydro-5-methoxy-1-(2-methoxy-1-methylethyl)-
- 665011-77-8/1-Piperazinecarboxylic acid, 4-[4-[(5S)-5-(3-amino-3-oxopropyl)-2-oxo-3-oxazolidinyl]-2-fluorophenyl] -, phenylmethyl ester
- 665011-78-9/1-Piperazinecarboxamide, 4-[4-[(5S)-5-[(acetylamino)methyl]-2-oxo-3-oxazolidinyl]-2-fluorophenyl]- N-(4-nitrophenyl)-
- 665011-79-0/1-Piperazinecarboxylic acid, 4-[4-[(5S)-5-(3-amino-3-oxopropyl)-2-oxo-3-oxazolidinyl]-2-fluorophenyl] -, 1,1-dimethylethyl ester
- 665011-80-3/1-Piperazinecarbothioamide, 4-[2-fluoro-4-[(5S)-2-oxo-5-[[(1-thioxoethyl)amino]methyl]-3-oxazolidinyl] phenyl]-N-(4-nitrophenyl)-
- 665011-81-4/Acetamide, N-[[(5S)-3-[3-fluoro-4-[4-(4-morpholinylcarbonyl)-1-piperazinyl]phenyl]-2 -oxo-5-oxazolidinyl]methyl]-
- 66501-18-6/3H-1,2,4-Triazol-3-one,5-ethoxy-1,2-dihydro-1-(2-methoxy-1-methylethyl)-(9CI)
- 66501-14-2/2-Quinoxalinecarboxamide, 3,7-dimethyl-, 1,4-dioxide
- 66501-13-1/2-Quinoxalinecarboxamide, 7-chloro-N-(hydroxymethyl)-3-methyl-, 1,4-dioxide
- 665011-30-3/Benzenethiol, 4,4'-[[2-[(1-methylethenyl)amino]-5-nitro-1,4-phenylene]di-2,1-ethynediyl ]bis-
- 665011-26-7/Methanol, (4-methylcyclohexylidene)-
- 66501-12-0/2-Quinoxalinecarboxamide, 7-chloro-3-methyl-, 1,4-dioxide
- 66501-11-9/2-Quinoxalinecarboxamide, 7-ethoxy-N-(hydroxymethyl)-3-methyl-, 1,4-dioxide
- 66501-10-8/2-Quinoxalinecarboxamide, 7-ethoxy-3-methyl-, 1,4-dioxide
- 66501-09-5/2-Quinoxalinecarboxamide, N-(hydroxymethyl)-7-methoxy-3-methyl-, 1,4-dioxide
- 66501-08-4/2-Quinoxalinecarboxamide, 7-methoxy-3-methyl-, 1,4-dioxide
- 665012-07-7/Acetamide, N-[[(5S)-3-[4-[4-[[(3,4-dichlorophenyl)amino]thioxomethyl]-1-piperazinyl] -3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]-
- 665012-01-1/Ethanethioamide, N-[[(5S)-3-[4-[4-(cyclopentylthioxomethyl)-1-piperazinyl]-3-fluorophenyl]- 2-oxo-5-oxazolidinyl]methyl]-
- 665012-00-0/Ethanethioamide, N-[[(5S)-3-[4-[4-(cyclobutylthioxomethyl)-1-piperazinyl]-3-fluorophenyl]-2 -oxo-5-oxazolidinyl]methyl]-
- 665011-99-4/Ethanethioamide, N-[[(5S)-3-[3-fluoro-4-[4-[(5-methylpyrazinyl)thioxomethyl]-1-piperazinyl] phenyl]-2-oxo-5-oxazolidinyl]methyl]-

 
               
       